Asn12 and Asn278: Critical Residues for In Vitro Biological Activity of Reteplase
Reteplase (rPA) is a thrombolytic agent used for the treatment of acute myocardial infarction. We studied the expression of rPA and its selected asparagine mutants after integration into the Pichia genome. Though methanol induction of the native and the rPA mutants showed similar expression levels (...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Wiley
2010-01-01
|
| Collection: | Advances in Hematology |
| Accès en ligne: | http://dx.doi.org/10.1155/2010/172484 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|